Belite Bio, Inc. Sponsored ADR BLTE

167.33 (2.11) (1.25%) as of 25 Sep
Market cap
$6.8B
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Net Income

+8 more quarters

(52.29) (25.32) 0.00 0.00
Depreciation & Amortization
0.35 0.12 — —
Non Cash Items (Other)
24.05 13.56 — —
Change in payables and accrued liability
2.01 1.84 — —
Change in other assets and liabilities
(0.49) (0.04) — —
Other operating activities
(0.23) (0.54) — —
Operating Cash Flow
(26.60) (10.38) — —
Capital expenditures
— (0.18) — —
Long-Term Investments Change (Net)
(1.37) (303.56) — —
Investing cash flow
(1.37) (303.73) — —
Equity Repurchase (Common, Net)
34.87 511.34 — —
Other financial activities
118.25 (1.22) — —
Financing cash flow
153.12 510.12 — —
Exchange Rate Adjustment
0.22 (0.10) — —
Change in Cash
125.36 195.90 — —
Beginning Cash
31.68 0.00 — —
Ending Cash
157.03 195.90 — —
Stock Based Compensation
27.21 11.71 — —
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
1.52 1.80 — —
Investments Change (Net)
(1.37) (303.56) — —
Issuance/Purchase of Shares
34.87 511.34 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates